The Chief Medical Officer, Sally Davies, caused a bit of a
stir a week or two ago. On BBC Radio 3’s “Private
Passions”, she acknowledged that she had taken cannabis a few times, in
cookies. This excited the Daily Mail, mostly for the apparent
scandal of a senior public (health) figure admitting to having taken illegal drugs. Ears also pricked up in the world of drug and
alcohol policy, though, as Davies stated that addiction was a ‘medical’
condition.
I’m not sure I agree. The term addiction isn’t clear. For a start, you can distinguish it from
physiological dependency, which can wane relatively quickly, while
addition persists – that is, if you follow the EMCDDA in defining addiction as
the “repeated
powerful motivation to engage in an activity with no survival value, acquired
through experience with that activity, despite the harm or risk of harm it
causes”. (On addiction, it’s worth listening to
the beginning of this
Radio 4 programme on addition, or reading this
book.)
To an extent this is simply to
acknowledge the psychological element of addiction, and that doesn’t in itself
mean the phenomenon isn’t medical.
However, I’d argue that this idea that addiction is – or should be
treated as – specifically or primarily medical is unhelpful.
We know that people’s health is
affected (even determined) by factors that might not be thought of as directly
medical: inequality,
housing, social networks, the built environment. And someone’s ability to overcome an
addiction is affected by their ‘recovery
capital’ – pretty much those exact same factors.
To suggest addiction is purely
medical runs the risk of implying that, as a physiological problem, detox or a
methadone script should resolve it. This
could detract from the attention that should be paid to secure housing,
employment, social networks and all those other factors that influence how
likely someone is to recover.
This is one of the reasons to be
cheerful about substance misuse treatment now being housed in local authorities
as part of public health structures: in theory, this should make it more likely
that public health interests will be taken into account across different areas
of local policy, from schooling, through transport and planning, to licensing.
In fact, it’s one of the reasons
to think that public health is the right place for substance misuse as an
agenda generally: public health should be about all these wider factors.
However, as I’ve suggested before,
given the way we understand and regulate intoxicants in the UK, health issues
aren’t the only ones that relate to substance misuse. For example, Paul
Hayes, former chief exec of the NTA, has noted the importance of the crime
agenda in garnering support for drug treatment within government.
As with the definition of
‘addiction’, it isn’t always clear what is meant when people talk about
drug-related crime. Peter
Ferentzy is probably right when he asserts that much violence described as
‘drug-related’ would be better described as ‘prohibition-related’, in the same
way as we talk about Al Capone’s exploits.
And the Guardian editorial that commented on
Davies’ point made a similar claim, but to hint at the advantages in
decriminalisation or legalisation.
This is of course one of the
underlying aims when people talk about treating addiction as a medical problem:
the ‘addict’ shouldn’t by definition be a criminal. But that’s different to Ferentzy’s argument,
where he’s talking about violence/crime relating to the trade in drugs, not the taking of the drugs. And being addicted
to something isn’t a crime in Britain.
What’s criminal is possession of illegal drugs. In fact, you can access physiological and
psychological treatment for addiction on the NHS. (I should actually say: via your local
authority through a range of local or national providers, public, private or
charities, but free at the point of use).
When we think of addiction as causing crime, we’re mostly
thinking about shoplifting
and so forth to fund a habit. And
that is drug-related. It might be
that legalisation could reduce crime – but only if people funded their use
without committing crime. One way that
could happen is if legalisation made drugs cheaper*, but this would seem
unlikely.
This is one of the reasons I’m
cautious about drug treatment budgets being placed within public health: a key
benefit of these services – and how these have been justified politically for
more than a decade – is their role in reducing crime.** Crime is only an indirect concern of public
health, in that it reflects and reinforces a lack of social capital and
security, which can affect health. It is
not included in the Public Health Outcomes Framework (PHOF)***, which is the
primary structure according to which public health activities will be driven.
The other reason I’ve been
cautious about the substance misuse agenda being housed within public health is
that the public health perspective tends to think in terms of population-wide
effects and activities. MUP is (to some
extent) a classic case of this, as James
Morris has pointed out. Although it
can be presented
as a targeted approach, one of its attractions is that although it would only
have a marginal effect on each individual’s consumption, when that marginal
reduction in risk is aggregated across the whole population, the effect on
morbidity/mortality is significant.
There’s been debate in the drugs and
alcohol treatment field – notably from Marcus Roberts of DrugScope – about how
this perspective might affect treatment services. The concern is that, actually, a very small
proportion of the population are in need of treatment for, say, heroin addiction,
and targeting an intervention on a small group is counter to this approach. (There is
anecdotal evidence there’s some grounds for this concern.) The old NTA
arguments, of course, are built around on this very point: that small
population of heroin users accounts for up to half of all acquisitive crime.
I’ve been concerned about this,
every time I hear discussions about drugs and alcohol drift to the problem of
those thousands who are drinking above government guidelines, or the seemingly growing
problem of drinking
amongst older people.
This is partly a turf war: I
think I have a natural tendency to want to defend the areas of work I’ve been
involved with.
It is partly from this insular
perspective that I’ve recently thought of a reason to be cheerful. Unfortunately, it undermines the reason to be
cheerful about public health moving to local authorities.
It seems to me that there aren’t
actually that many population-wide policies that can be implemented at a local
authority level. The most striking
population-wide policy – MUP – would
require a national policy, despite
the hopes of local directors of public health. Local initiatives – such
as this one in Bournemouth – have proved fleeting, and tend to be voluntary.
Or think of putting cigarettes
behind screens. It’s hard to imagine
local authorities being able to persuade multi-national operators to introduce
this only in one area.
Of course, there are areas where local
public health could make a difference – in fact, all those I mentioned above:
transport, planning, education… The
difference is that in those areas the aim isn’t to introduce (or spend money on)
public health policies; it’s to influence existing policy or activity by
adding a public health perspective.
It’s harder to think of population-wide
projects that are simultaneously local that public health could spend
its considerable budget on. There could
be universal education and information campaigns, but
it’s not clear that these have significant effects. Rather, local public health campaigns are
likely to be targeted interventions – those proposals to address older people’s
drinking would would be targeted rather than population-wide, for example. In fact, local public health teams are quite used
to targeting particular areas. For
better or worse (and mostly simply for convenience) public health initiatives
often focus on ready-made communities – most often working through schools, but
also by targeting particular geographical areas.
So my reason to be cheerful is
that in fact drug treatment could be justified in these terms; it is the
targeting of a specific ‘problem’ group.
What I’m hoping, though, is that
Public Health keeps that wider view and manages to have that same influence on
other departments and functions of local government.
*My understanding is that there is
less acquisitive crime related to alcohol addiction because this is a
cheaper habit. Of course, the flip side
of this is that there’s a considerable amount of alcohol-related violent crime
related to drunkenness, separate from dependence/addiction, which we might
assume would fall if alcohol was less affordable and therefore less was
consumed
**Police and Crime Commissioners
(PCCs) do have some money that historically went towards substance misuse
treatment designed specifically for those with a criminal justice connection
(the Drug Interventions Programme – DIP), but this was only a small proportion
of the overall spend on these services, and in many cases is unlikely to
continue to be put towards treatment.
***Violent crime rates are included in the PHOF. However, these crimes, if they are related to intoxicants, tend to be linked with alcohol and/or ‘recreational’ drugs used in the night-time economy, rather than the crimes typically associated with addiction specifically. I should also note that treatment outcomes for opiate users are included, but only defined in terms of the proportion of those in treatment who complete successfully in the past year.. This means that you could scale back the scale of drug treatment and still maintain (even improve) performance on this metric.
***Violent crime rates are included in the PHOF. However, these crimes, if they are related to intoxicants, tend to be linked with alcohol and/or ‘recreational’ drugs used in the night-time economy, rather than the crimes typically associated with addiction specifically. I should also note that treatment outcomes for opiate users are included, but only defined in terms of the proportion of those in treatment who complete successfully in the past year.. This means that you could scale back the scale of drug treatment and still maintain (even improve) performance on this metric.